Table 1: Baseline differences between patients who did not receive the loading dose of bevacizumab and those who did.
N, ≥ 3 injections | N, < 3 injections | ||||
p-value | OR | CI | |||
Area of residence (rural) | 441 | 128 | < 0.001 | 1.54 | 1.23 - 1.92 |
Marital status (non-married) | 1892 | 396 | 0.32 | 1.09 | 0.92 - 1.29 |
Gender (female) | 1942 | 412 | 0.15 | 1.13 | 0.95 - 1.30 |
Socio-economic level (low) | 1080 | 210 | 0.59 | 0.95 | 0.79 - 1.14 |
Anxiety | 409 | 79 | 0.72 | 0.95 | 0.73 - 1.24 |
Depression | 567 | 105 | 0.39 | 0.91 | 0.72 - 1.15 |
Alcohol abuse | 14 | 4 | 0.53 | 1.42 | 0.39 - 4.62 |
TIA | 145 | 41 | 0.06 | 1.41 | 0.97 - 2.04 |
CVA | 483 | 94 | 0.66 | 0.95 | 0.74 - 1.21 |
CHF | 402 | 86 | 0.06 | 1.33 | 0.98 - 1.8 |
MI | 685 | 148 | 0.32 | 1.11 | 0.9 - 1.36 |
TIA: Transient Ischemic Attack; CVA: Cerebrovascular Accident; CHF: Congestive Heart Failure; MI: Myocardial Infarction.